Traws Pharma (TRAW) Other Accumulated Expenses (2012 - 2025)

Traws Pharma (TRAW) posted quarterly Other Accumulated Expenses of $128000.0 for Q4 2025, up 814.29% quarter-over-quarter from $14000.0 in Q1 2019.

Traws Pharma (TRAW) Other Accumulated Expenses (2012 - 2025) Analysis & Trends

Traws Pharma (TRAW) has reported Other Accumulated Expenses for 9 consecutive years, with $128000.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $128000.0; the TTM figure through Dec 2025 stood at $128000.0 (changed N/A YoY), while the FY2025 annual figure was $128000.0, changed N/A from the prior year.
Other Accumulated Expenses grew to $128000.0 in Q4 2025 per TRAW's latest filing, from $14000.0 in the prior quarter.
Across five years, Other Accumulated Expenses topped out at $128000.0 in Q4 2025 and bottomed at $128000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Traws Pharma	5.66 Mn	639,491.99	-

Download Data